HAYWARD, Calif.--(BUSINESS WIRE)--
Impax Laboratories, Inc. (NASDAQ: IPXL) announced today that the
Company will release its fourth quarter and full year 2012 financial
results on Monday, February 25, 2013, after the close of the U.S.
financial markets. The Company will host a conference call and live
webcast with the investment community at 4:30 p.m., Eastern Time on
February 25, 2013.
The financial results and live webcast will be accessible through the
Investor Relations section of the Company's Web site, www.impaxlabs.com.
To access the call through a conference line, dial (877) 356-3814 (in
the U.S.) and (706) 758-0033 (international callers). The conference ID
is 90423980.
A replay of the conference call will be available for seven days shortly
after the call. To access the replay, dial (855) 859-2056 (in the U.S.)
and (404) 537-3406 (international callers). The access code for the
replay is 90423980.
About Impax Laboratories, Inc.
Impax Laboratories, Inc. (NASDAQ: IPXL) is a technology based specialty
pharmaceutical company applying its formulation expertise and drug
delivery technology to the development of controlled-release and
specialty generics in addition to the development of branded products.
Impax markets its generic products through its Global Pharmaceuticals
division and markets its branded products through the Impax
Pharmaceuticals division. Additionally, where strategically appropriate,
Impax has developed marketing partnerships to fully leverage its
technology platform. Impax Laboratories is headquartered in Hayward,
California, and has a full range of capabilities in its Hayward,
Philadelphia and Taiwan facilities. For more information, please visit
the Company's Web site at: www.impaxlabs.com.
Source: Impax Laboratories, Inc.